Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ratner, L.
Right arrow Articles by Straus, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ratner, L.
Right arrow Articles by Straus, D.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
Journal of Clinical Oncology, Vol 19, Issue 8 (April), 2001: 2171-2178
© 2001 American Society for Clinical Oncology

Chemotherapy for Human Immunodeficiency Virus–Associated Non-Hodgkin’s Lymphoma in Combination With Highly Active Antiretroviral Therapy

By Lee Ratner, Jeannette Lee, Shenghui Tang, David Redden, Fayez Hamzeh, Brian Herndier, David Scadden, Lawrence Kaplan, Richard Ambinder, Alexandra Levine, William Harrington, Louise Grochow, Charles Flexner, Benjamin Tan, David Straus, for the AIDS Malignancy Consortium

From the AIDS Malignancy Consortium Operation Center, University of Alabama, Birmingham, AL.

Address reprint requests to Lee Ratner, MD, PhD, Washington University, Box 8069, 660 S. Euclid, St Louis, MO 63110; email: lratner{at}imgate.wust1.edu

PURPOSE: This study investigated the efficacy, toxicity, and pharmacokinetic interactions resulting from simultaneous combination chemotherapy and highly active antiretroviral therapy (HAART) for patients with human immunodeficiency virus (HIV)-associated non-Hodgkin’s lymphoma (NHL). In addition, the effects on viral load, CD4 counts, and opportunistic infections were examined with the use of combination chemotherapy combined with HAART.

PATIENTS AND METHODS: Sixty-five patients with previously untreated and measurable disease at any stage of HIV-associated NHL of intermediate or high grade were entered onto this study at 17 different centers. The first 40 patients entered onto the study received reduced doses of cyclophosphamide and doxorubicin, combined with vincristine and prednisone (modified CHOP [mCHOP]), whereas the subsequent 25 patients entered onto the study received full doses of CHOP combined with granulocyte colony-stimulating factor (G-CSF). All patients also received stavudine, lamivudine, and indinavir.

RESULTS: The complete response rates were 30% and 48% among patients who received mCHOP and full-dose CHOP combined with HAART, respectively. Grade 3 or 4 neutropenia occurred in 25% of patients receiving mCHOP and 12% of those receiving full-dose CHOP combined with G-CSF (25% v 12%). There were similar numbers of patients with grade 3 or 4 hyperbilirubinemia (12% and 17%), constipation and abdominal pain (18% and 17%), and transaminase elevation (48% and 52%) on the modified and full-dose arms of the study, respectively. Doxorubicin clearance and indinavir concentration curves were similar among patients on this study and historical controls, whereas cyclophosphamide clearance was 1.5-fold reduced as compared with control values. Human immunodeficiency virus (HIV) load declined from a median baseline value of 29,000 copies/mL to a median minimum value on therapy of 500 copies/mL.

CONCLUSION: Either modified-dose or full-dose CHOP chemotherapy for HIV-NHL, delivered with HAART, is effective and tolerable.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 JCOHome page
P. Balsalobre, J. L. Diez-Martin, A. Re, M. Michieli, J. M. Ribera, C. Canals, A. Rosselet, E. Conde, R. Varela, K. Cwynarski, et al.
Autologous Stem-Cell Transplantation in Patients With HIV-Related Lymphoma
J. Clin. Oncol., May 1, 2009; 27(13): 2192 - 2198.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Bower, J. Stebbing, M. Tuthill, V. Campbell, J. Krell, P. Holmes, A. Ozzard, M. Nelson, B. Gazzard, and T. Powles
Immunologic recovery in survivors following chemotherapy for AIDS-related non-Hodgkin lymphoma
Blood, April 15, 2008; 111(8): 3986 - 3990.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
J.-S. Kim, S. J. Kim, J.-S. Kim, E. S. Kim, H.-J. Shin, J. S. Chung, Y.-H. Min, M. H. Lee, Y. J. Choi, S.-M. Bang, et al.
Report of Aids-related Lymphoma in South Korea
Jpn. J. Clin. Oncol., February 8, 2008; (2008) hym168v1.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
L. Galicier, C. Fieschi, R. Borie, V. Meignin, M.-T. Daniel, L. Gerard, and E. Oksenhendler
Intensive chemotherapy regimen (LMB86) for St Jude stage IV AIDS-related Burkitt lymphoma/leukemia: a prospective study
Blood, October 15, 2007; 110(8): 2846 - 2854.
[Abstract] [Full Text] [PDF]

Home page
 J Oncol Pharm PractHome page
R. Schlichemeyer, C. Chambers, and M. J. Gill
The oncology impact of highly active antiretroviral therapy
Journal of Oncology Pharmacy Practice, March 1, 2007; 13(1): 17 - 25.
[Abstract] [PDF]

Home page
 QJMHome page
C. Palmieri, T. Treibel, O. Large, and M. Bower
AIDS-related non-Hodgkin's lymphoma in the first decade of highly active antiretroviral therapy
QJM, December 1, 2006; 99(12): 811 - 826.
[Abstract] [Full Text] [PDF]

Home page
 ASH ANNUAL MEETING ABSTRACTSHome page
J. Orem, O.W. Mwanda, P. Fu, C. Banura, J. Kakembo, A. Ness, J. Johnson, V. Subbiah, J. Bako, J. Black, et al.
Dose-Modified Oral Chemotherapy for AIDS-Related Non-Hodgkin's Lymphoma (AR-NHL) in East Africa.
Blood (ASH Annual Meeting Abstracts), November 16, 2006; 108(11): 488 - 488.
[Abstract] [PDF]

Home page
 BloodHome page
J. Singh, A. K. Malani, S. Ganguly, S. Kambhampati, and N. Mounier
HAART- and AIDS-related lymphomas.
Blood, November 15, 2006; 108(10): 3621 - 3622.
[Full Text] [PDF]

Home page
 JCOHome page
T. J. Smith, J. Khatcheressian, G. H. Lyman, H. Ozer, J. O. Armitage, L. Balducci, C. L. Bennett, S. B. Cantor, J. Crawford, S. J. Cross, et al.
2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline
J. Clin. Oncol., July 1, 2006; 24(19): 3187 - 3205.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
M. Hentrich, L. Maretta, K. U. Chow, J. R. Bogner, D. Schurmann, P. Neuhoff, H. Jager, D. Reichelt, M. Vogel, M. Ruhnke, et al.
Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin's disease: results of a multicenter study
Ann. Onc., June 1, 2006; 17(6): 914 - 919.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
S. Combs, N. Neil, and D. M. Aboulafia
Liposomal Doxorubicin, Cyclophosphamide, and Etoposide and Antiretroviral Therapy for Patients with AIDS-Related Lymphoma: A Pilot Study.
Oncologist, June 1, 2006; 11(6): 666 - 673.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
N. Mounier, M. Spina, J. Gabarre, M. Raphael, G. Rizzardini, J.-B. Golfier, E. Vaccher, A. Carbone, B. Coiffier, G. Chichino, et al.
AIDS-related non-Hodgkin lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapy
Blood, May 15, 2006; 107(10): 3832 - 3840.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
H. Masur
Management of Patients with HIV in the Intensive Care Unit.
Proceedings of the ATS, January 1, 2006; 3(1): 96 - 102.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
W. H. Navarro and L. D. Kaplan
AIDS-related lymphoproliferative disease
Blood, January 1, 2006; 107(1): 13 - 20.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S.-T. Lim, R. Karim, B. N. Nathwani, A. Tulpule, and A. M. Levine
In Reply:
J. Clin. Oncol., November 1, 2005; 23(31): 8133 - 8134.
[Full Text] [PDF]

Home page
 BloodHome page
L. D. Kaplan, J. Y. Lee, R. F. Ambinder, J. A. Sparano, E. Cesarman, A. Chadburn, A. M. Levine, and D. T. Scadden
Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010
Blood, September 1, 2005; 106(5): 1538 - 1543.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. Hoffmann, M. Tiemann, C. Schrader, D. Janssen, E. Wolf, M. Vierbuchen, R. Parwaresch, K. Ernestus, A. Plettenberg, A. Stoehr, et al.
AIDS-related B-cell lymphoma (ARL): correlation of prognosis with differentiation profiles assessed by immunophenotyping
Blood, September 1, 2005; 106(5): 1762 - 1769.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
M. Bower, B. Gazzard, S. Mandalia, T. Newsom-Davis, C. Thirlwell, T. Dhillon, A. M. Young, T. Powles, A. Gaya, M. Nelson, et al.
A Prognostic Index for Systemic AIDS-Related Non-Hodgkin Lymphoma Treated in the Era of Highly Active Antiretroviral Therapy
Ann Intern Med, August 16, 2005; 143(4): 265 - 273.
[Abstract] [Full Text] [PDF]

Home page
 CA Cancer J ClinHome page
S. T. Lim and A. M. Levine
Recent Advances in Acquired Immunodeficiency Syndrome (AIDS)-related Lymphoma
CA Cancer J Clin, July 1, 2005; 55(4): 229 - 241.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. T. Lim, R. Karim, B. N. Nathwani, A. Tulpule, B. Espina, and A. M. Levine
AIDS-Related Burkitt's Lymphoma Versus Diffuse Large-Cell Lymphoma in the Pre-Highly Active Antiretroviral Therapy (HAART) and HAART Eras: Significant Differences in Survival With Standard Chemotherapy
J. Clin. Oncol., July 1, 2005; 23(19): 4430 - 4438.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
M. C. Cheung, L. Pantanowitz, and B. J. Dezube
AIDS-Related Malignancies: Emerging Challenges in the Era of Highly Active Antiretroviral Therapy
Oncologist, June 1, 2005; 10(6): 412 - 426.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
M. Cruciani, G. Gatti, E. Vaccher, G. Di Gennaro, R. Cinelli, M. Bassetti, U. Tirelli, and D. Bassetti
Pharmacokinetic interaction between chemotherapy for non-Hodgkin's lymphoma and protease inhibitors in HIV-1-infected patients
J. Antimicrob. Chemother., April 1, 2005; 55(4): 546 - 549.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Spina, U. Jaeger, J. A. Sparano, R. Talamini, C. Simonelli, M. Michieli, G. Rossi, E. Nigra, M. Berretta, C. Cattaneo, et al.
Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials
Blood, March 1, 2005; 105(5): 1891 - 1897.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. Bower, T. Powles, J. Stebbing, and C. Thirlwell
Potential Antiretroviral Drug Interactions With Cyclophosphamide, Doxorubicin, and Etoposide
J. Clin. Oncol., February 20, 2005; 23(6): 1328 - 1329.
[Full Text] [PDF]

Home page
 Ann OncolHome page
G. Toffoli, G. Corona, G. Cattarossi, M. Boiocchi, G. Di Gennaro, U. Tirelli, and E. Vaccher
Effect of highly active antiretroviral therapy (HAART) on pharmacokinetics and pharmacodynamics of doxorubicin in patients with HIV-associated non-Hodgkin's lymphoma
Ann. Onc., December 1, 2004; 15(12): 1805 - 1809.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Bower, N. McCall-Peat, N. Ryan, L. Davies, A. M. Young, S. Gupta, M. Nelson, B. Gazzard, and J. Stebbing
Protease inhibitors potentiate chemotherapy-induced neutropenia
Blood, November 1, 2004; 104(9): 2943 - 2946.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. M. Levine, A. Tulpule, B. Espina, A. Sherrod, W. D. Boswell, R. D. Lieberman, B. N. Nathwani, and L. Welles
Liposome-Encapsulated Doxorubicin in Combination With Standard Agents (cyclophosphamide, vincristine, prednisone) in Patients With Newly Diagnosed AIDS-Related Non-Hodgkin's Lymphoma: Results of Therapy and Correlates of Response
J. Clin. Oncol., July 1, 2004; 22(13): 2662 - 2670.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. Stebbing, B. Gazzard, S. Mandalia, A. Teague, A. Waterston, V. Marvin, M. Nelson, and M. Bower
Antiretroviral Treatment Regimens and Immune Parameters in the Prevention of Systemic AIDS-Related Non-Hodgkin's Lymphoma
J. Clin. Oncol., June 1, 2004; 22(11): 2177 - 2183.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
R. Gastaldi, P. Martino, G. Gentile, M. S. De Propris, M. F. Pirillo, A. De Vellis, and F. Mandelli
High dose of idarubicin-based regimen for diffuse large cell AIDS-related non-Hodgkin's lymphoma with or without antiretroviral therapy during antineoplastic agents
Ann. Onc., December 1, 2003; 14(12): 1792 - 1794.
[Full Text] [PDF]

Home page
 NEJMHome page
L. D. Kaplan, N. A. Afridi, G. Holmvang, and L. R. Zukerberg
Case 31-2003 - A 44-Year-Old Man with HIV Infection and a Right Atrial Mass
N. Engl. J. Med., October 2, 2003; 349(14): 1369 - 1377.
[Full Text] [PDF]

Home page
 BloodHome page
R. F. Little, S. Pittaluga, N. Grant, S. M. Steinberg, M. F. Kavlick, H. Mitsuya, G. Franchini, M. Gutierrez, M. Raffeld, E. S. Jaffe, et al.
Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology
Blood, June 15, 2003; 101(12): 4653 - 4659.
[Abstract] [Full Text] [PDF]

Home page
 ASH Education BookHome page
P. A. Volberding, K. R. Baker, and A. M. Levine
Human Immunodeficiency Virus Hematology
Hematology, January 1, 2003; 2003(1): 294 - 313.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
M. W. Otieno, C. Banura, E. Katongole-Mbidde, J. L. Johnson, M. Ghannoum, A. Dowlati, R. Renne, E. Arts, C. Whalen, M. M. Lederman, et al.
Therapeutic Challenges of AIDS-Related Non-Hodgkin's Lymphoma in the United States and East Africa
J Natl Cancer Inst, May 15, 2002; 94(10): 718 - 732.
[Abstract] [Full Text] [PDF]

Home page
 ASH Education BookHome page
A. M. Levine, D. T. Scadden, J. A. Zaia, and A. Krishnan
Hematologic Aspects of HIV/AIDS
Hematology, January 1, 2001; 2001(1): 463 - 478.
[Abstract] [Full Text] [PDF]


About
JCO		 Editorial
Roster		 Advertising
Information		 Librarians &
Institutions		 Rights &
Permissions		 PDA Services

Copyright © 2001 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online